Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Potentiation of adverse effects of cold by warm ischemia in circulatory death donors for porcine liver transplantation.

Monbaliu D, Liu Q, Vekemans K, Roskams T, Pirenne J.

Transplant Proc. 2012 Nov;44(9):2874-9. doi: 10.1016/j.transproceed.2012.09.078.

PMID:
23146545
2.

Graft reconditioning with nitric oxide gas in rat liver transplantation from cardiac death donors.

Kageyama S, Yagi S, Tanaka H, Saito S, Nagai K, Hata K, Fujimoto Y, Ogura Y, Tolba R, Shinji U.

Transplantation. 2014 Mar 27;97(6):618-25. doi: 10.1097/TP.0000000000000025.

3.

Recombinant human soluble thrombomodulin (ART-123) prevents warm ischemia-reperfusion injury in liver grafts from non-heart-beating donors.

Kashiwadate T, Miyagi S, Hara Y, Akamatsu Y, Kawagishi N, Sekiguchi S, Satomi S.

Transplant Proc. 2012 Mar;44(2):369-72. doi: 10.1016/j.transproceed.2012.01.036.

PMID:
22410019
4.

Outcomes of liver transplantations using donations after circulatory death: a single-center experience.

Meurisse N, Vanden Bussche S, Jochmans I, Francois J, Desschans B, Laleman W, Van der Merwe S, Van Steenbergen W, Cassiman D, Verslype C, Aerts R, Nevens F, Pirenne J, Monbaliu D.

Transplant Proc. 2012 Nov;44(9):2868-73. doi: 10.1016/j.transproceed.2012.09.077.

5.

[Experimental study on tolerance time limits from warm ischemia to cold preservation of liver grafts].

Zheng SG, Feng XB, He ZP, Qing DK, Leng JJ, Dong JH.

Zhonghua Gan Zang Bing Za Zhi. 2006 Apr;14(4):250-4. Chinese.

PMID:
16635290
6.

Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity.

Monbaliu D, Vekemans K, Hoekstra H, Vaahtera L, Libbrecht L, Derveaux K, Parkkinen J, Liu Q, Heedfeld V, Wylin T, Deckx H, Zeegers M, Balligand E, Buurman W, van Pelt J, Porte RJ, Pirenne J.

Ann Surg. 2009 Nov;250(5):808-17. doi: 10.1097/SLA.0b013e3181bdd787.

PMID:
19826248
7.

Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.

Dulkanchainun TS, Goss JA, Imagawa DK, Shaw GD, Anselmo DM, Kaldas F, Wang T, Zhao D, Busuttil AA, Kato H, Murray NG, Kupiec-Weglinski JW, Busuttil RW.

Ann Surg. 1998 Jun;227(6):832-40.

8.

The clinical relevance of the anhepatic phase during liver transplantation.

Ijtsma AJ, van der Hilst CS, de Boer MT, de Jong KP, Peeters PM, Porte RJ, Slooff MJ.

Liver Transpl. 2009 Sep;15(9):1050-5. doi: 10.1002/lt.21791.

9.

Rewarming preservation by organ perfusion system for donation after cardiac death liver grafts in pigs.

Matsuno N, Obara H, Watanabe R, Iwata S, Kono S, Fujiyama M, Hirano T, Kanazawa H, Enosawa S.

Transplant Proc. 2014 May;46(4):1095-8. doi: 10.1016/j.transproceed.2013.12.035.

PMID:
24815137
10.

Edaravone, a free radical scavenger, improves the graft viability on liver transplantation from non-heart-beating donors in pigs.

Miyazawa K, Miyagi S, Maida K, Murakami K, Fujio A, Kashiwadate T, Nakanishi W, Hara Y, Nakanishi C, Yamaya H, Kawagishi N, Goto M, Ohuchi N.

Transplant Proc. 2014 May;46(4):1090-4. doi: 10.1016/j.transproceed.2013.11.155.

PMID:
24815136
11.

Improving the function of liver grafts exposed to warm ischemia by the Leuven drug protocol: exploring the molecular basis by microarray.

Vekemans K, Monbaliu D, Balligand E, Heedfeld V, Jochmans I, Pirenne J, van Pelt J.

Liver Transpl. 2012 Feb;18(2):206-18. doi: 10.1002/lt.22446.

12.

Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs.

Monbaliu D, van Pelt J, De Vos R, Greenwood J, Parkkinen J, Crabbé T, Zeegers M, Vekemans K, Pincemail J, Defraigne JO, Fevery J, Pirenne J.

Liver Transpl. 2007 Feb;13(2):239-47.

13.

Livers from non-heart-beating donors tolerate short periods of warm ischemia.

Monbaliu D, Crabbé T, Roskams T, Fevery J, Verwaest C, Pirenne J.

Transplantation. 2005 May 15;79(9):1226-30.

PMID:
15880075
14.

Preservation of porcine non-heart-beating donor livers by sequential cold storage and warm perfusion.

Reddy SP, Bhattacharjya S, Maniakin N, Greenwood J, Guerreiro D, Hughes D, Imber CJ, Pigott DW, Fuggle S, Taylor R, Friend PJ.

Transplantation. 2004 May 15;77(9):1328-32.

PMID:
15167586
15.

Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft.

Gong J, Lao XJ, Zhang SJ, Chen S.

Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):481-4.

16.

One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac death.

de Rougemont O, Breitenstein S, Leskosek B, Weber A, Graf R, Clavien PA, Dutkowski P.

Ann Surg. 2009 Nov;250(5):674-83. doi: 10.1097/SLA.0b013e3181bcb1ee.

PMID:
19806056
17.

Impact of venous systemic oxygen persufflation supplemented with nitric oxide gas on cold-stored, warm ischemia-damaged experimental liver grafts.

Srinivasan PK, Yagi S, Doorschodt B, Nagai K, Afify M, Uemoto S, Tolba R.

Liver Transpl. 2012 Feb;18(2):219-25. doi: 10.1002/lt.22442.

18.

Cold ischemia/reperfusion injury in a mouse model of partial liver transplantation.

Wang G, Hu B, Li Z.

J Surg Res. 2013 May;181(2):337-41. doi: 10.1016/j.jss.2012.06.068. Epub 2012 Jul 20.

PMID:
22831564
19.

Liver transplantation following donation after cardiac death: an analysis using matched pairs.

Pine JK, Aldouri A, Young AL, Davies MH, Attia M, Toogood GJ, Pollard SG, Lodge JP, Prasad KR.

Liver Transpl. 2009 Sep;15(9):1072-82. doi: 10.1002/lt.21853.

20.

The tolerance time limits of biliary tracts of liver grafts subjected to warm ischemia and cold preservation: an experimental study in swine.

Zheng S, Feng X, Qing D, Chen M, Dong J.

Transplant Proc. 2008 Jun;40(5):1629-34. doi: 10.1016/j.transproceed.2008.01.072.

PMID:
18589163

Supplemental Content

Support Center